Nigeria

Resilience System


You are here

Government

Pfizer, BioNTech formally seek emergency use of COVID-19 shots in US

Pfizer formally asked U.S. regulators Friday to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.

Problem, Solution, SitRep, or ?: 

The Vaccines Will Probably Work. Making Them Fast Will Be the Hard Part.

The promising news that not just one but two coronavirus vaccines were more than 90 percent effective in early results has buoyed hopes that an end to the pandemic is in sight.

But even if the vaccines are authorized soon by federal regulators — the companies developing them have said they expect to apply soon — only a sliver of the American public will be able to get one by the end of the year. The two companies, Pfizer and Moderna, have estimated they will have 45 million doses, or enough to vaccinate 22.5 million Americans, by January.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Government
howdy folks
Page loaded in 1.056 seconds.